compounded semaglutide fda news US proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs The FDA Can't Decide Whether

Your body needs protein and nutrients to keep your hair follicles fed and healthy

That includes a patient based in New Hampshire named Amy, who said she began taking the Wegovy pill in early February

Comparing the GLP-1 Pill and the Shot The key to success with a GLP-1 medication is to keep taking it

Low protein intake before or during treatment Hair needs amino acids at every stage of the cycle

If your patients are wondering if one of these drugs might be a fit, you can recommend they consult a healthcare provider

Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) Retatrutide (LY3437943) is Eli Lilly's triple GLP-1/GIP/glucagon receptor agonist in Phase III clinical trials